Moreover, different genetic approaches of inhibiting hematopoietic transcription factor NF-κB, a key regulator of inflammation via TLRs and CLRs recognition, did not only attenuate29 but also promoted30 atherosclerotic plaque formation indicating its crucial role in both pro- and anti-inflammatory processes in atherosclerosis. The gene discussed is NFKB1; the disease is atherosclerosis.